At ImmunoQs, we believe every cancer patient is unique. Our core mission is to enhance patient outcomes in modern cancer therapies. We are a spin-off company from the Agency for Science, Technology and Research (A*STAR), Singapore. We offer comprehensive suites of specialized services to clinicians, scientists, and drug developers, focusing on spatial omics, immune monitoring and digital analytics, meticulously tailored to address specific clinical needs and scientific questions in immuno-oncology.
| Website | https://immunoqs.com/ |
| Employees | 8 (5 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Patient Outcomes, Cancer Therapies, Immuno-Oncology, Precision Oncology, Immunotherapy, Personalized Medicine, Cancer Research, Targeted Therapy, Oncology, Cancer Treatment, Biotechnology, Cancer Diagnostics, Therapeutics, Pharmaceutical, Molecular Diagnostics, Cancer Biomarkers, Drug Development, Biomarkers, Clinical Trials, Drug Discovery |
| Competitors | Roche, Thermo Fisher Scientific, Abbott, Novartis, BD, Merck Group, Agilent Technologies, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN +41 more (view full list) |
Looking for a particular ImmunoQs employee's phone or email?
ImmunoQs Questions
Lit-Hsin Loo is the Co-Founder and CEO of ImmunoQs.
5 people are employed at ImmunoQs.
Top ImmunoQs Employees
-
2
-
1
-
Joey Lee
Co-Founder and COO at ImmunoQs
Singapore1
G2Crowd Trusted
300K+
Plugin Users
